(Q40098391)

17 September 2017

title

Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy (English)

1 reference

17 September 2017

1 reference

Jian-Qing Wu

1

1 reference

17 September 2017

Wei-Hong Zhao

2

1 reference

17 September 2017

Yan Li

3

1 reference

17 September 2017

Bei Zhu

4

1 reference

17 September 2017

Kai-Sheng Yin

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

6 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

368

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

309-316

1 reference

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Gamma-rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk/ganciclovir on cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Cancer immunotherapy: breaking the barriers to harvest the crop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Enhancing rAAV vector expression in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2007.07.006

1 reference

17 September 2017

1 reference